- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.64 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x SPD: SPERMIDINE(Non-covalent)
- 2 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
EDO.2: 6 residues within 4Å:- Chain A: L.89, Q.91, E.263, R.266, L.267, T.270
3 PLIP interactions:3 interactions with chain A- Hydrogen bonds: A:L.89, A:E.263, A:R.266
EDO.8: 6 residues within 4Å:- Chain C: L.89, Q.91, E.263, R.266, L.267, T.270
3 PLIP interactions:3 interactions with chain C- Hydrogen bonds: C:L.89, C:E.263, C:R.266
- 4 x NAD: NICOTINAMIDE-ADENINE-DINUCLEOTIDE(Non-covalent)
NAD.3: 30 residues within 4Å:- Chain A: T.106, S.107, N.108, L.109, S.111, T.133, A.134, G.135, E.138, E.139, I.168, D.240, G.284, G.285, I.308, N.309, T.310, A.311, A.343, D.344, A.345
- Chain B: G.286, V.287, H.290, D.315, S.317, D.318, S.319
- Ligands: SPD.4, NAD.6
24 PLIP interactions:9 interactions with chain B, 15 interactions with chain A- Hydrogen bonds: B:G.286, B:D.318, B:S.319, B:S.319, B:S.319, B:S.319, A:S.107, A:S.107, A:N.108, A:S.111, A:T.133, A:A.134, A:G.135, A:E.139, A:D.240, A:G.285, A:T.310, A:D.344, A:A.345
- Water bridges: B:V.287, B:S.317, B:D.318, A:N.108, A:N.108
NAD.6: 30 residues within 4Å:- Chain A: G.286, V.287, H.290, D.315, S.317, D.318, S.319
- Chain B: T.106, S.107, N.108, L.109, S.111, T.133, A.134, G.135, E.138, E.139, I.168, D.240, G.284, G.285, I.308, N.309, T.310, A.311, A.343, D.344, A.345
- Ligands: SPD.1, NAD.3
25 PLIP interactions:8 interactions with chain A, 17 interactions with chain B- Hydrogen bonds: A:G.286, A:D.318, A:S.319, A:S.319, A:S.319, A:S.319, B:S.107, B:S.107, B:N.108, B:S.111, B:T.133, B:A.134, B:G.135, B:E.139, B:D.240, B:G.285, B:T.310, B:T.310, B:D.344, B:A.345
- Water bridges: A:V.287, A:S.317, B:N.108, B:N.108, B:G.285
NAD.9: 30 residues within 4Å:- Chain C: T.106, S.107, N.108, L.109, S.111, T.133, A.134, G.135, E.138, E.139, I.168, D.240, G.284, G.285, I.308, N.309, T.310, A.311, A.343, D.344, A.345
- Chain D: G.286, V.287, H.290, D.315, S.317, D.318, S.319
- Ligands: SPD.10, NAD.12
26 PLIP interactions:18 interactions with chain C, 8 interactions with chain D- Hydrogen bonds: C:T.106, C:S.107, C:S.107, C:N.108, C:S.111, C:T.133, C:T.133, C:A.134, C:G.135, C:E.139, C:G.285, C:T.310, C:T.310, C:D.344, C:D.344, C:A.345, D:G.286, D:D.318, D:S.319, D:S.319, D:S.319, D:S.319
- Water bridges: C:N.108, C:N.108, D:V.287, D:S.317
NAD.12: 30 residues within 4Å:- Chain C: G.286, V.287, H.290, D.315, S.317, D.318, S.319
- Chain D: T.106, S.107, N.108, L.109, S.111, T.133, A.134, G.135, E.138, E.139, I.168, D.240, G.284, G.285, I.308, N.309, T.310, A.311, A.343, D.344, A.345
- Ligands: SPD.7, NAD.9
27 PLIP interactions:9 interactions with chain C, 18 interactions with chain D- Hydrogen bonds: C:G.286, C:D.318, C:S.319, C:S.319, C:S.319, C:S.319, D:T.106, D:S.107, D:S.107, D:N.108, D:S.111, D:T.133, D:T.133, D:A.134, D:G.135, D:E.139, D:G.285, D:T.310, D:D.344, D:D.344, D:A.345
- Water bridges: C:V.287, C:S.317, C:D.318, D:N.108, D:N.108, D:G.285
- 2 x MRD: (4R)-2-METHYLPENTANE-2,4-DIOL(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Wator, E. et al., Cryo-EM structure of human eIF5A-DHS complex reveals the molecular basis of hypusination-associated neurodegenerative disorders. Nat Commun (2023)
- Release Date
- 2023-04-05
- Peptides
- Deoxyhypusine synthase: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
AD
B
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.64 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x SPD: SPERMIDINE(Non-covalent)
- 2 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
- 4 x NAD: NICOTINAMIDE-ADENINE-DINUCLEOTIDE(Non-covalent)
- 2 x MRD: (4R)-2-METHYLPENTANE-2,4-DIOL(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Wator, E. et al., Cryo-EM structure of human eIF5A-DHS complex reveals the molecular basis of hypusination-associated neurodegenerative disorders. Nat Commun (2023)
- Release Date
- 2023-04-05
- Peptides
- Deoxyhypusine synthase: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
AD
B